These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30099437)

  • 1. Mortality Effects of Prolonged Hemoperfusion Therapy Using a Polymyxin B-Immobilized Fiber Column for Patients with Septic Shock: A Sub-Analysis of the DESIRE Trial.
    Kawazoe Y; Sato T; Miyagawa N; Yokokawa Y; Kushimoto S; Miyamoto K; Ohta Y; Morimoto T; Yamamura H
    Blood Purif; 2018; 46(4):309-314. PubMed ID: 30099437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.
    Yamashita C; Hara Y; Kuriyama N; Nakamura T; Nishida O
    Ther Apher Dial; 2015 Aug; 19(4):316-23. PubMed ID: 26386218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Effects and Outcomes After Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Treatment for Septic Shock in Preterm Neonates.
    Nishizaki N; Hara T; Obinata K; Nakagawa M; Shimizu T
    Pediatr Crit Care Med; 2020 Feb; 21(2):156-163. PubMed ID: 31568052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock.
    Mitaka C; Tsuchida N; Kawada K; Nakajima Y; Imai T; Sasaki S
    Shock; 2009 Nov; 32(5):478-83. PubMed ID: 19295483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
    Mitaka C; Tomita M
    Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period.
    Mitaka C; Fujiwara N; Yamamoto M; Toyofuku T; Haraguchi G; Tomita M
    J Crit Care; 2014 Oct; 29(5):728-32. PubMed ID: 24798345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock.
    Chihara S; Masuda Y; Tatsumi H; Nakano K; Shimada T; Murohashi T; Yamakage M
    J Artif Organs; 2017 Mar; 20(1):71-75. PubMed ID: 27469940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
    Cruz DN; Antonelli M; Fumagalli R; Foltran F; Brienza N; Donati A; Malcangi V; Petrini F; Volta G; Bobbio Pallavicini FM; Rottoli F; Giunta F; Ronco C
    JAMA; 2009 Jun; 301(23):2445-52. PubMed ID: 19531784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoperfusion with polymyxin B-immobilized fiber attenuates the increased plasma levels of thrombomodulin and von Willebrand factor from patients with septic shock.
    Nakamura T; Suzuki Y; Shimada N; Ebihara I; Shoji H; Koide H
    Blood Purif; 1998; 16(4):179-86. PubMed ID: 9736787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended Sessions of Polymyxin-B Immobilized Fiber Column Hemoperfusion Ameliorate Renal Outcome and Mortality in Septic Shock with Acute Kidney Injury.
    Maekawa H; Negishi K
    Blood Purif; 2018; 46(2):81-89. PubMed ID: 29672307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
    Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
    Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.
    Berto P; Ronco C; Cruz D; Melotti RM; Antonelli M
    Blood Purif; 2011; 32(4):331-40. PubMed ID: 22086346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock.
    Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Koide H
    Am J Med Sci; 2007 Oct; 334(4):244-7. PubMed ID: 18030179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.
    Dellinger RP; Bagshaw SM; Antonelli M; Foster DM; Klein DJ; Marshall JC; Palevsky PM; Weisberg LS; Schorr CA; Trzeciak S; Walker PM;
    JAMA; 2018 Oct; 320(14):1455-1463. PubMed ID: 30304428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers.
    Ono S; Kimura A; Hiraki S; Takahata R; Tsujimoto H; Kinoshita M; Miyazaki H; Yamamoto J; Hase K; Saitoh D
    Surgery; 2013 Feb; 153(2):262-71. PubMed ID: 22884251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin adsorption: Direct hemoperfusion with the polymyxin B-immobilized fiber column (PMX).
    Shimizu T; Miyake T; Kitamura N; Tani M; Endo Y
    Transfus Apher Sci; 2017 Oct; 56(5):682-688. PubMed ID: 28923774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
    Kase Y; Obata T; Okamoto Y; Iwai K; Saito K; Yokoyama K; Takinami M; Tanifuji Y
    Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis.
    Chang T; Tu YK; Lee CT; Chao A; Huang CH; Wang MJ; Yeh YC
    Crit Care Med; 2017 Aug; 45(8):e858-e864. PubMed ID: 28445237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of polymyxin B convalently immobilized fiber in patients with septic shock.
    Suzuki H; Shoji H
    Contrib Nephrol; 2010; 166():150-157. PubMed ID: 20473003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock.
    Nakamura T; Suzuki T; Kawagoe Y; Koide H
    ASAIO J; 2008; 54(2):210-3. PubMed ID: 18356658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.